NEUCA S.A. (WSE: NEU)

Poland flag Poland · Delayed Price · Currency is PLN
840.00
+2.00 (0.24%)
Jan 21, 2025, 5:01 PM CET
-3.11%
Market Cap 3.75B
Revenue (ttm) 12.34B
Net Income (ttm) 161.38M
Shares Out 4.47M
EPS (ttm) 35.59
PE Ratio 23.60
Forward PE 17.01
Dividend 14.50 (1.73%)
Ex-Dividend Date Jun 12, 2024
Volume 312
Average Volume 987
Open 838.00
Previous Close 838.00
Day's Range 833.00 - 844.00
52-Week Range 730.00 - 969.00
Beta 0.45
RSI 44.13
Earnings Date Mar 28, 2025

About NEUCA

NEUCA S.A. engages in the wholesale distribution of pharmaceuticals in Poland. It operates through Wholesale Distribution of Medicines, Manufacture of Pharmaceuticals, Medical Operator, Clinical Trials, and Insurance Activities segments. The company owns and produces Rx, OTC medicines, dietary supplements, medical devices, dermocosmetics, hygiene products, personal protective equipment, as well as diagnostic and dressing materials under the Świat Zdrowia, APTEO, GENOPTIM, CERA+ Solutions, and Kic Kic brand names to pharmacists, medical doctors,... [Read more]

Sector Healthcare
Founded 1990
Employees 4,633
Stock Exchange Warsaw Stock Exchange
Ticker Symbol NEU
Full Company Profile

Financial Performance

In 2023, NEUCA's revenue was 11.81 billion, an increase of 5.17% compared to the previous year's 11.23 billion. Earnings were 146.27 million, an increase of 6.58%.

Financial Statements

News

There is no news available yet.